ImmunoGen Inc
XBER:IMU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
ImmunoGen Inc
XBER:IMU
|
US |
|
Promotora y Operadora de Infraestructura SAB de CV
OTC:PUODY
|
MX |
|
Subsea 7 SA
LSE:0OGK
|
UK |
|
C
|
Chime Financial Inc
NASDAQ:CHYM
|
US |
|
ARMOUR Residential REIT Inc
F:2AR
|
US |
|
Cosmo Pharmaceuticals NV
LSE:0RGI
|
IE |
|
Evercore Inc
NYSE:EVR
|
US |
|
Semler Scientific Inc
F:6FA
|
US |
|
N
|
NVIDIA Corp
BMV:NVDA
|
US |
|
M
|
Metso Oyj
OMXH:METSO
|
FI |
|
Allbirds Inc
F:8W80
|
US |
|
Ryanair Holdings PLC
ISEQ:RYA
|
IE |
|
W
|
Western Union Co
SWB:W3U
|
US |
|
Maisons du Monde SA
OTC:MDOUF
|
FR |
|
F5 Inc
NASDAQ:FFIV
|
US |
|
M
|
Marathon Oil Corp
F:USS
|
US |
|
M
|
Micron Technology Inc
XETRA:MTE
|
US |
|
Qiagen NV
MIL:1QGEN
|
NL |
|
A
|
American International Group Inc
BMV:AIG
|
US |
|
I
|
Insulet Corp
SWB:GOV
|
US |
|
S
|
Service Corporation International
SWB:SVC
|
US |
Bankruptcy Probability
ImmunoGen Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
ImmunoGen Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
I
|
ImmunoGen Inc
XETRA:IMU
|
1.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
371.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
176.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
160.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
OpGen Inc
NASDAQ:OPGN
|
239.9m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
73.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
42.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
ImmunoGen Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, ImmunoGen Inc has total debt of 88.6m USD. This includes both short-term (0 USD) and long-term (88.6m USD) debt.
You can find a full breakdown on its Balance Sheet.
